These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28716235)

  • 1. Psychosis in Parkinson's disease: From the soft signs to the hard science.
    Lenka A; Herath P; Christopher R; Pal PK
    J Neurol Sci; 2017 Aug; 379():169-176. PubMed ID: 28716235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.
    Lenka A; Jhunjhunwala KR; Saini J; Pal PK
    Parkinsonism Relat Disord; 2015 Jul; 21(7):683-91. PubMed ID: 25920541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic substrates of psychosis in patients with Parkinson's disease: A critical review.
    Lenka A; Arumugham SS; Christopher R; Pal PK
    J Neurol Sci; 2016 May; 364():33-41. PubMed ID: 27084212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of cognitive impairment in patients with Parkinson's disease and psychosis: A critical review.
    Lenka A; Hegde S; Arumugham SS; Pal PK
    Parkinsonism Relat Disord; 2017 Apr; 37():11-18. PubMed ID: 28057432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
    Lee AH; Weintraub D
    Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis.
    Lenka A; Ingalhalikar M; Shah A; Saini J; Arumugham SS; Hegde S; George L; Reddy V; Reddy YCJ; Yadav R; Pal PK
    J Neural Transm (Vienna); 2018 Sep; 125(9):1361-1372. PubMed ID: 29858658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    Ffytche DH; Pereira JB; Ballard C; Chaudhuri KR; Weintraub D; Aarsland D
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):325-331. PubMed ID: 28315846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    Nishio Y; Yokoi K; Uchiyama M; Mamiya Y; Watanabe H; Gang M; Baba T; Takeda A; Hirayama K; Mori E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):722-729. PubMed ID: 28600444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Understanding of Psychosis in Parkinson's Disease.
    Ojo OO; Fernandez HH
    Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neurotransmitters in the development of Parkinson's disease-related psychosis.
    Factor SA; McDonald WM; Goldstein FC
    Eur J Neurol; 2017 Oct; 24(10):1244-1254. PubMed ID: 28758318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive correlates of hallucinations and delusions in Parkinson's disease.
    Factor SA; Scullin MK; Sollinger AB; Land JO; Wood-Siverio C; Zanders L; Freeman A; Bliwise DL; McDonald WM; Goldstein FC
    J Neurol Sci; 2014 Dec; 347(1-2):316-21. PubMed ID: 25466695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered subcortical emotional salience processing differentiates Parkinson's patients with and without psychotic symptoms.
    Knolle F; Garofalo S; Viviani R; Justicia A; Ermakova AO; Blank H; Williams GB; Arrondo G; Ramachandra P; Tudor-Sfetea C; Bunzeck N; Duezel E; Robbins TW; Barker RA; Murray GK
    Neuroimage Clin; 2020; 27():102277. PubMed ID: 32540629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging behavioural complications of Parkinson's disease.
    Valli M; Mihaescu A; Strafella AP
    Brain Imaging Behav; 2019 Apr; 13(2):323-332. PubMed ID: 28856542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis in Parkinson's disease: identification, prevention and treatment.
    Levin J; Hasan A; Höglinger GU
    J Neural Transm (Vienna); 2016 Jan; 123(1):45-50. PubMed ID: 25894288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis in Parkinson's Disease: A Lesson from Genetics.
    Angelopoulou E; Bougea A; Papageorgiou SG; Villa C
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease.
    Hermanowicz S; Hermanowicz N
    Expert Rev Neurother; 2016 Jun; 16(6):625-33. PubMed ID: 26908168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of psychosis in Parkinson's disease.
    Fénelon G; Alves G
    J Neurol Sci; 2010 Feb; 289(1-2):12-7. PubMed ID: 19740486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.
    Chang A; Fox SH
    Drugs; 2016 Jul; 76(11):1093-118. PubMed ID: 27312429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-related psychosis: pathophysiology with therapeutical strategies.
    Wolters ECh
    J Neural Transm Suppl; 2006; (71):31-7. PubMed ID: 17447413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.